Table 4.
EM (200 patients*) | PM (18 patients**) | p-value | |||
---|---|---|---|---|---|
n | % | n | % | ||
No toxicity | 62 | 31 | 7 | 39 | p =0.7875 (Pearson’s chi-square test) |
G1-G2 toxicities | 112 | 56 | 9 | 50 | |
Severe toxicities | 26 | 13 | 2 | 11 |
EM (200 patients*) | PM (18 patients**) | p-value | |||
---|---|---|---|---|---|
n | % | n | % | ||
No toxicity | 62 | 31 | 7 | 39 | p =0.7875 (Pearson’s chi-square test) |
G1-G2 toxicities | 112 | 56 | 9 | 50 | |
Severe toxicities | 26 | 13 | 2 | 11 |